T2 Biosystems Inc. [NASDAQ: TTOO] traded at a low on 04/06/21, posting a -7.69 loss after which it closed the day’ session at $1.56. The company report on March 30, 2021 that T2 Biosystems CEO Shares Personal Heart Transplant and Sepsis Survival Story in Newly Released Book.
All proceeds from the book sale will be donated to Sepsis Alliance and Donate Life America.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced that CEO John Sperzel released a book about his personal experience with a bloodstream infection (BSI) and sepsis, titled “Courage: Powerful Lessons in Leadership, Strength, and the Will to Succeed.”.
The results of the trading session contributed to over 3640297 shares changing hands. Over the past one week, the price volatility of T2 Biosystems Inc. stands at 7.85% while the volatility over the past one month is 10.85%.
The market cap for TTOO stock reached $238.37 million, with 148.21 million shares outstanding and 140.78 million shares in the current float. Compared to the average trading volume of 13.13M shares, TTOO reached a trading volume of 3640297 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about T2 Biosystems Inc. [TTOO]?
Alliance Global Partners have made an estimate for T2 Biosystems Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on January 27, 2021. While these analysts kept the previous recommendation, BTIG Research raised their target price to Buy. The new note on the price target was released on October 08, 2020, representing the official price target for T2 Biosystems Inc. stock.
The Average True Range (ATR) for T2 Biosystems Inc. is set at 0.19, with the Price to Sales ratio for TTOO stock in the period of the last 12 months amounting to 13.17. The Price to Book ratio for the last quarter was 26.00, with the Price to Cash per share for the same quarter was set at 0.28.
How has TTOO stock performed recently?
T2 Biosystems Inc. [TTOO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.30. With this latest performance, TTOO shares dropped by -2.50% in over the last four-week period, additionally plugging by 16.42% over the last 6 months – not to mention a rise of 208.61% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TTOO stock in for the last two-week period is set at 40.90, with the RSI for the last a single of trading hit 39.95, and the three-weeks RSI is set at 42.82 for T2 Biosystems Inc. [TTOO]. The present Moving Average for the last 50 days of trading for this stock 2.2133, while it was recorded at 1.5970 for the last single week of trading, and 1.5868 for the last 200 days.
T2 Biosystems Inc. [TTOO]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and T2 Biosystems Inc. [TTOO] shares currently have an operating margin of -221.72 and a Gross Margin at -13.87. T2 Biosystems Inc.’s Net Margin is presently recorded at -258.12.
Return on Total Capital for TTOO is now -102.55, given the latest momentum, and Return on Invested Capital for the company is -289.22. When it comes to the capital structure of this company, T2 Biosystems Inc. [TTOO] has a Total Debt to Total Equity ratio set at 652.29. Additionally, TTOO Total Debt to Total Capital is recorded at 86.71, with Total Debt to Total Assets ending up at 71.98. Long-Term Debt to Equity for the company is recorded at 639.10, with the Long-Term Debt to Total Capital now at 84.95.
Reflecting on the efficiency of the workforce at the company, T2 Biosystems Inc. [TTOO] managed to generate an average of -$316,203 per employee. Receivables Turnover for the company is 4.58 with a Total Asset Turnover recorded at a value of 0.34.T2 Biosystems Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.10 and a Current Ratio set at 5.50.
Earnings analysis for T2 Biosystems Inc. [TTOO]
With the latest financial reports released by the company, T2 Biosystems Inc. posted -0.22/share EPS, while the average EPS was predicted by analysts to be reported at -0.23/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 4.30%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TTOO.
Insider trade positions for T2 Biosystems Inc. [TTOO]
There are presently around $33 million, or 14.50% of TTOO stock, in the hands of institutional investors. The top three institutional holders of TTOO stocks are: VANGUARD GROUP INC with ownership of 6,185,575, which is approximately 15.307% of the company’s market cap and around 0.30% of the total institutional ownership; GOLDMAN SACHS GROUP INC, holding 4,358,817 shares of the stock with an approximate value of $6.8 million in TTOO stocks shares; and BLACKROCK INC., currently with $3.44 million in TTOO stock with ownership of nearly 0.023% of the company’s market capitalization.
Positions in T2 Biosystems Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 39 institutional holders increased their position in T2 Biosystems Inc. [NASDAQ:TTOO] by around 4,572,158 shares. Additionally, 22 investors decreased positions by around 1,387,447 shares, while 16 investors held positions by with 15,441,354 shares. The mentioned changes placed institutional holdings at 21,400,959 shares, according to the latest SEC report filing. TTOO stock had 20 new institutional investments in for a total of 1,559,069 shares, while 10 institutional investors sold positions of 650,943 shares during the same period.